Utilizing Generic Drug Awareness to Improve Patient Outcomes with Dr. Sarah Ibrahim
In this episode of the Q&A with FDA podcast, learn about Utilizing Generic Drug Awareness to Improve Patient Outcomes with Dr. Sarah Ibrahim from FDA’s Office of Generic Drugs.
--------
23:30
Real-World Data and Evidence Generation with Dr. Hilary Marston
In this episode of the Q&A with FDA podcast, learn about real world evidence, real world data, and how FDA continues to advance clinical trials and promote reliable evidence to support the safety and effectiveness of drug products with Dr. Hilary Marston, FDA’s Chief Medical Officer.
--------
21:00
The Role of Artificial Intelligence in Clinical Trial Design and Research with Dr. ElZarrad
Listen to a soundcast of the May 8, 2024, Q&A with FDA: The Role of Artificial Intelligence in Clinical Trial Design and Research with Dr. ElZarrad.
--------
23:58
Switching Between Biosimilars and Their Reference Counterparts with Dr. Sarah Yim
Listen to our latest podcast series, Q&A with FDA, on Switching Between Biosimilars and Their Reference Counterparts, featuring Dr. Sarah Yim.
--------
12:13
The Current Status of Oral Phenylephrine as a Nasal Decongestant with Dr. Theresa Michele and Dr. Ilisa Bernstein
The Current Status of Oral Phenylephrine as a Nasal Decongestant with Dr. Theresa Michele and Dr. Ilisa Bernstein
"Q&A with FDA" provides engaging conversation and discussion about the latest regulatory topics. In this podcast series, FDA’s Division of Drug Information will answer some of the most commonly asked questions received by FDA.
Italia